These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30830867)

  • 41. A Facile, In Vitro 384-Well Plate System to Model Disseminated Tumor Cells in the Bone Marrow Microenvironment.
    Buschhaus JM; Luker KE; Luker GD
    Methods Mol Biol; 2018; 1686():201-213. PubMed ID: 29030823
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional Up-Regulation of FBXW7 by K
    Ohya S; Kito H; Kajikuri J; Yamaguchi Y; Matsui M
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
    Rack B; Zombirt E; Trapp E; Jückstock J; Andergassen U; Neugebauer J; Kost B; Weissenbacher T; Jeschke U; Schindlbeck C; Janni W; Alunni-Fabbroni M
    Oncology; 2016; 90(4):232-8. PubMed ID: 26937631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
    Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
    Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FBXW7 in breast cancer: mechanism of action and therapeutic potential.
    Chen S; Leng P; Guo J; Zhou H
    J Exp Clin Cancer Res; 2023 Sep; 42(1):226. PubMed ID: 37658431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR.
    Zhang B; Zhao R; He Y; Fu X; Fu L; Zhu Z; Fu L; Dong JT
    Oncotarget; 2016 Feb; 7(5):5702-14. PubMed ID: 26744318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
    Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
    Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
    Walter VP; Taran FA; Wallwiener M; Walter C; Grischke EM; Wallwiener D; Brucker SY; Hartkopf AD
    Breast Cancer Res Treat; 2018 Jun; 169(2):305-309. PubMed ID: 29374853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.
    Bourgeois-Daigneault MC; St-Germain LE; Roy DG; Pelin A; Aitken AS; Arulanandam R; Falls T; Garcia V; Diallo JS; Bell JC
    Breast Cancer Res; 2016 Aug; 18(1):83. PubMed ID: 27503504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.
    Marsden CG; Wright MJ; Carrier L; Moroz K; Rowan BG
    PLoS One; 2012; 7(11):e47587. PubMed ID: 23173031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score.
    Hartkopf AD; Wallwiener M; Kommoss S; Taran FA; Brucker SY
    Breast Cancer Res Treat; 2016 Feb; 156(1):91-5. PubMed ID: 26911294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FBXW7 mediates chemotherapeutic sensitivity and prognosis in NSCLCs.
    Yokobori T; Yokoyama Y; Mogi A; Endoh H; Altan B; Kosaka T; Yamaki E; Yajima T; Tomizawa K; Azuma Y; Onozato R; Miyazaki T; Tanaka S; Kuwano H
    Mol Cancer Res; 2014 Jan; 12(1):32-7. PubMed ID: 24165483
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High Bak Expression Is Associated with a Favorable Prognosis in Breast Cancer and Sensitizes Breast Cancer Cells to Paclitaxel.
    Luo Y; Wang X; Wang H; Xu Y; Wen Q; Fan S; Zhao R; Jiang S; Yang J; Liu Y; Li X; Xiong W; Ma J; Peng S; Zeng Z; Li X; Phillips JB; Li G; Tan M; Zhou M
    PLoS One; 2015; 10(9):e0138955. PubMed ID: 26406239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7.
    Gong J; Cui Z; Li L; Ma Q; Wang Q; Gao Y; Sun H
    Tumour Biol; 2015 Sep; 36(10):7831-40. PubMed ID: 25944166
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinoma.
    Li MR; Zhu CC; Ling TL; Zhang YQ; Xu J; Zhao EH; Zhao G
    BMC Gastroenterol; 2017 May; 17(1):60. PubMed ID: 28464881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner.
    Jiang G; Shi W; Fang H; Zhang X
    Mol Med Rep; 2018 Dec; 18(6):5417-5426. PubMed ID: 30365154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer.
    Zeng WG; Li JJ; Hu P; Lei L; Wang JN; Liu RB
    Oncol Rep; 2013 Jun; 29(6):2355-61. PubMed ID: 23525624
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells.
    Möhrmann L; Zowada MK; Strakerjahn H; Siegl C; Kopp-Schneider A; Krunic D; Strunk D; Schneider M; Kriegsmann M; Kriegsmann K; Herbst F; Ball CR; Glimm H; Dieter SM
    Int J Cancer; 2020 Jul; 147(2):519-531. PubMed ID: 32077087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
    Chang J; Sui M; Fan W
    Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.